Top Clinical Trials companies in Denmark by Receivables

This ranking features the top 2 Clinical Trials companies in Denmark ranked by Receivables, totalling a Receivables of USD 732.50 M, for January 15, 2025.

Denmark

Clinical Trials
Receivables
#
Name
Receivables
 Reported Date
Stock Price
Change
 Price (30 days) Country
1
GMAB.CO

Genmab A/S

1

GMAB.CO
USD 732.25 M
Dec. 31, 2023 USD 216.88 1.28%

Denmark
2
SANION.ST

Saniona AB (publ)

2

SANION.ST
USD 249.32 K
Dec. 31, 2023 USD 0.57 1.47%

Denmark
Frequently Asked Questions
  • Which Clinical Trials company in Denmark has the highest Receivables ?

    The Clinical Trials company in Denmark with the highest Receivables is Genmab A/S (Copenhagen Stock Exchange: GMAB.CO) at USD 732.25 M.

  • Which Clinical Trials company in Denmark has the lowest Receivables ?

    The Clinical Trials company in Denmark with the lowest Receivables is Saniona AB (publ) (Stockholm Stock Exchange: SANION.ST) at USD 249.32 K.

  • What are the top 10 Clinical Trials companies in Denmark by Receivables ?

    The top 10 Clinical Trials companies in Denmark by Receivables are Genmab A/S and Saniona AB (publ).

  • What are the bottom 10 Clinical Trials companies in Denmark by Receivables ?

    The bottom 10 Clinical Trials companies in Denmark by Receivables are Saniona AB (publ) and Genmab A/S.